張俊欽醫師 Chun -Chin Chang, M.D.

  • 信箱

  • 電話

  • 個人連結

  • 職位

    現職: 臺北榮民總醫院內科部心臟科主治醫師 教職: 國立陽明大學內科學科講師

  • 學經歷

    國立陽明大學醫學士

經      歷 :
  臺北榮民總醫院內科部住院醫師
  臺北榮民總醫院內科心臟內科總醫師
  日本神戶大學附設醫院心導管室進修醫師
  臺北榮民總醫院桃園分院心臟內科主治醫師
  Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands 客座研究員
  Cardialysis Academic Research Team
  EuroIntervention local associate editor
   
專長學科:
  成人心臟內科
  冠狀動脈介入治療
  周邊血管介入治療
  洗腎廔管血管成型術
  臨床試驗
   
專科證書:
  中華民國內科專科醫師
  中華民國心臟專科醫師
  中華民國心臟血管介入專科醫師
  中華民國重症醫學專科醫師
   
專科學會:
  中華民國內科醫學會
  中華民國心臟學會
  台灣介入性心臟血管醫學會
  歐洲心臟學會
  歐洲介入性心臟心管醫學會
   
  1. Chang CC, Veen KM, Hahn RT, Bogers AJJC, Latib A, Oei FBS, Abdelghani M,  Modolo R, Ho SY,  Abdel-Wahab M, Fattouch K, Bosmans J, Caliskan K, Taramasso M, Serruys PW, Bax JJ, van Mieghem NMDA,  Takkenberg JJM, Lurz P, Modine T, Soliman O. Uncertainties and challenges in surgical and transcatheter tricuspid  valve  therapy: a state-of-the-art expert review.  Eur Heart J. 2019 Sep 11. pii: ehz614.
  2. Chang CC, Kogame N, Onuma Y, Byrne RA, Capodanno D, Windecker S, Morel MA, Cutlip DE, Krucoff MW, Stone GW,  Lansky AJ, Mehran R, Spitzer E, Fraser  AG, Baumbach A, Serruys PW.  Defining Device Success for Percutaneous Coronary  Intervention Trials: A Position Statement from the European Association of    Percutaneous Cardiovascular Interventions of the European Society of Cardiology. EuroIntervention. 2019 Sep 3. pii: EIJ-D-19-00552.
  3. Chang CC, Kogame N, Asano T, von Birgelen C, Sabaté M, Onuma Y, Serruys  PW.  BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable  polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the  PIONEER trial.  EuroIntervention. 2019 Jul 30. pii: EIJ-D-19-00566.
  4. Chang CC, Onuma Y, Achenbach S, Barbato E, Chevalier B, Cook S, Dudek D, Escaned J, Gori T, Kočka V, Tarantini G, West NEJ, Morice MC, Tijssen JGP, van  Geuns RJ, Smits PC;   COMPARE ABSORB trial investigators.  Absorb   Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis  Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial. Cardiovasc Revasc Med.  2019 Jul;20(7):577-582.
  5. Zaman A, de Winter RJ, Kogame N, Chang CC, Modolo R, Spitzer E, Tonino P, Hofma S, Zurakowski A, Smits PC, Prokopczuk J, Moreno R, Choudhury A, Petrov     I, Cequier A, Kukreja N, Hoye A, Iniguez A, Ungi I, Serra A, Gil RJ, Walsh S,  Tonev G, Mathur A, Merkely B, Colombo A, Ijsselmuiden S, Soliman O, Kaul U, Onuma Y, Serruys PW; TALENT trial investigators.  Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic  lesions (TALENT): a prospective multicentre randomised controlled trial.  Lancet.     2019 Mar 9;393(10175):987-997.
  6.  Asano T, Katagiri Y, Chang CC, Kogame N, Chichareon P, Takahashi K, Modolo R,    Tenekecioglu E, Collet C, Jonker H, Appleby C, Zaman A, van Mieghem N, Uren N,  Zueco J, Piek JJ, Reiber JHC, Farooq V,  Escaned J, Banning AP, Serruys PW,  Onuma Y. Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial:   Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical  Prognostic Value of Functional SYNTAX Score Derived From Quantitative  Flow Ratio in Patients With 3-Vessel Disease.  JACC Cardiovasc Interv. 2019 Feb  11;12(3):259-270.
  7. Modolo R, Chang CC, Tateishi H, Miyazaki Y, Pighi M, Abdelghani M, Roos MA,  Wolff Q, Wykrzykowska JJ, de Winter RJ, Piazza N, Richardt G, Abdel-Wahab M, Soliman OII, Onuma Y, Van Mieghem NM, Serruys PW.   Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results    of the multicentre ASSESS-REGURGE Registry. EuroIntervention. 2019 Aug 29;15(5):420-426.
限於篇幅,以上謹為代表著作